OBJECTIVE: Phosphodiesterase 4 (PDE4) catabolizes the second messenger 3', 5'-cyclic adenosine monophosphate and may play a critical role in brain diseases. Our aim was to quantify PDE4 in rats with positron emission tomography (PET). METHODS: High (n = 6) and low specific activity (SA) (n = 2) higher affinity ((R)-[(11)C]rolipram) and high SA lower affinity ((S)-[(11)C]rolipram) (n = 2) enantiomers were intravenously administered to Sprague-Dawley rats. Brain data were acquired using the ATLAS PET scanner and reconstructed using the 3D-ordered subset expectation maximization algorithm. Arterial samples were taken to measure unmetabolized [(11)C]rolipram. Total distribution volumes (V(T)') were calculated using a 1-tissue compartment (1C) and an unconstrained 2-tissue compartment (2C) model. RESULTS: High SA R experiments showed later and greater brain uptake, and slower washout than low SA R and S experiments. In all regions and in all experiments, the 2C model gave significantly better fitting than the 1C model. The poor fitting by the latter caused underestimation of V(T)' by 19-31%. The 2C model identified V(T)' reasonably well with coefficients of variation less than 10%. V(T)' values by this model were 16.4-29.2 mL/cm(3) in high SA R, 2.9-3.5 in low SA R, and 3.1-3.7 in S experiments. CONCLUSIONS: Specific binding of (R)-[(11)C]rolipram was accurately measured in living rats. In high SA R experiments, approximately 86% of V(T)' was specific binding. Distribution and changes of PDE4 in animal models can now be studied by measuring V(T)' of high SA (R)-[(11)C]rolipram.
OBJECTIVE: Phosphodiesterase 4 (PDE4) catabolizes the second messenger 3', 5'-cyclic adenosine monophosphate and may play a critical role in brain diseases. Our aim was to quantify PDE4 in rats with positron emission tomography (PET). METHODS: High (n = 6) and low specific activity (SA) (n = 2) higher affinity ((R)-[(11)C]rolipram) and high SA lower affinity ((S)-[(11)C]rolipram) (n = 2) enantiomers were intravenously administered to Sprague-Dawley rats. Brain data were acquired using the ATLAS PET scanner and reconstructed using the 3D-ordered subset expectation maximization algorithm. Arterial samples were taken to measure unmetabolized [(11)C]rolipram. Total distribution volumes (V(T)') were calculated using a 1-tissue compartment (1C) and an unconstrained 2-tissue compartment (2C) model. RESULTS: High SA R experiments showed later and greater brain uptake, and slower washout than low SA R and S experiments. In all regions and in all experiments, the 2C model gave significantly better fitting than the 1C model. The poor fitting by the latter caused underestimation of V(T)' by 19-31%. The 2C model identified V(T)' reasonably well with coefficients of variation less than 10%. V(T)' values by this model were 16.4-29.2 mL/cm(3) in high SA R, 2.9-3.5 in low SA R, and 3.1-3.7 in S experiments. CONCLUSIONS: Specific binding of (R)-[(11)C]rolipram was accurately measured in living rats. In high SA R experiments, approximately 86% of V(T)' was specific binding. Distribution and changes of PDE4 in animal models can now be studied by measuring V(T)' of high SA (R)-[(11)C]rolipram.
Authors: Mireille Lortie; Jean N DaSilva; Miran Kenk; Stephanie Thorn; Darryl Davis; David Birnie; Rob S B Beanlands; Robert A deKemp Journal: Mol Imaging Biol Date: 2012-04 Impact factor: 3.488
Authors: Paolo Zanotti-Fregonara; Sami S Zoghbi; Jeih-San Liow; Elise Luong; Ronald Boellaard; Robert L Gladding; Victor W Pike; Robert B Innis; Masahiro Fujita Journal: Neuroimage Date: 2010-10-26 Impact factor: 6.556
Authors: Maarten Ooms; Tetsuya Tsujikawa; Talakad G Lohith; Sanché N Mabins; Sami S Zoghbi; Akiko Sumitomo; Hanna Jaaro-Peled; Yasuyuki Kimura; Sanjay Telu; Victor W Pike; Toshifumi Tomoda; Robert B Innis; Akira Sawa; Masahiro Fujita Journal: J Cereb Blood Flow Metab Date: 2018-02-12 Impact factor: 6.200
Authors: Paolo Zanotti-Fregonara; Christina S Hines; Sami S Zoghbi; Jeih-San Liow; Yi Zhang; Victor W Pike; Wayne C Drevets; Alan G Mallinger; Carlos A Zarate; Masahiro Fujita; Robert B Innis Journal: Neuroimage Date: 2012-08-10 Impact factor: 6.556
Authors: Tetsuji Itoh; Kohji Abe; Sami S Zoghbi; Osamu Inoue; Jinsoo Hong; Masao Imaizumi; Victor W Pike; Robert B Innis; Masahiro Fujita Journal: J Nucl Med Date: 2009-04-16 Impact factor: 10.057
Authors: David R Sprague; Masahiro Fujita; Yong Hoon Ryu; Jeih-San Liow; Victor W Pike; Robert B Innis Journal: Nucl Med Biol Date: 2008-05 Impact factor: 2.408